Evidence map›Paper›PMID 42218720›Full record

ArticleBriefings in bioinformatics2026

HighRes_Builder: improved access and modeling of noncanonical residues for protein structure prediction.

Yanchao Han, Jianfeng Mei, Gaoshuai Li, Enkang Dai, Hanlei Lu, Chengyun Zhang, Yanlu Zhang, Chenshui Lin, Chuanlong Zeng, Hongliang Duan and 1 more

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yanchao HanCollege of Pharmaceutical Sciences, Zhejiang University of Technology, No. 18 Chaowang Road, Gongshu District, Hangzhou, Zhejiang 310014, China.ORCID 0009-0005-9208-0814
Jianfeng MeiCollege of Pharmaceutical Sciences, Zhejiang University of Technology, No. 18 Chaowang Road, Gongshu District, Hangzhou, Zhejiang 310014, China.
Gaoshuai LiCollege of Pharmaceutical Sciences, Zhejiang University of Technology, No. 18 Chaowang Road, Gongshu District, Hangzhou, Zhejiang 310014, China.
Enkang DaiCollege of Pharmaceutical Sciences, Zhejiang University of Technology, No. 18 Chaowang Road, Gongshu District, Hangzhou, Zhejiang 310014, China.
Hanlei LuCollege of Pharmaceutical Sciences, Zhejiang University of Technology, No. 18 Chaowang Road, Gongshu District, Hangzhou, Zhejiang 310014, China.
Chengyun ZhangFaculty of Applied Sciences, Macao Polytechnic University, R. de Luís Gonzaga Gomes, Macao 999078, China.ORCID 0000-0002-8499-5273
Yanlu ZhangCollege of Pharmaceutical Sciences, Zhejiang University of Technology, No. 18 Chaowang Road, Gongshu District, Hangzhou, Zhejiang 310014, China.
Chenshui LinCollege of Pharmaceutical Sciences, Zhejiang University of Technology, No. 18 Chaowang Road, Gongshu District, Hangzhou, Zhejiang 310014, China.
Chuanlong ZengUniversity of Chinese Academy of Sciences, No. 19A Yuquan Road, Shijingshan District, Beijing 100049, China.
Hongliang DuanFaculty of Applied Sciences, Macao Polytechnic University, R. de Luís Gonzaga Gomes, Macao 999078, China.
Xudong WangCollege of Pharmaceutical Sciences, Zhejiang University of Technology, No. 18 Chaowang Road, Gongshu District, Hangzhou, Zhejiang 310014, China.

Funding

Horizontal Project KYY-HX-20210848Macao Polytechnic University RP/FCA-11/2025Macao Science and Technology Development Fund 0029/2025/RIB1'Pioneer' and 'Leading Goose' R&D Program of Zhejiang 2025C01094R&D Program of Zhejiang 2025C01094
6 · The paper itself

Abstract

The growing support for noncanonical amino acids in structure prediction tools such as AlphaFold3 has been largely facilitated by the Chemical Component Dictionary (CCD). However, the limited coverage of modified residues in CCD continues to restrict the application of these models to many biologically and therapeutically relevant peptides. To address this gap, we present HighRes_Builder, a computational method for efficient residue search and automated construction of noncanonical amino acids not currently archived in CCD. We demonstrate the utility of our approach by predicting structures for 3179 noncanonical residues beyond the CCD using AlphaFold3. AlphaFold3 achieved 100% acceptance for both the noncanonical residue monomers and their corresponding 'GGXGG' motifs (where X denotes the noncanonical residue). Of these, 72.44% of the predicted residue monomer structures concurrently satisfy all five geometric criteria (d_N_C1, d_Ck_Ccarb, d_Ccarb_O_mean, ang_Ck_Ccarb_O_mean, and ang_O1_Ccarb_O2). Furthermore, among the generated motif structures, 85.78% exhibited favorable ω values for the embedded noncanonical residues. Furthermore, by integrating HighRes_Builder with structure prediction systems, AlphaFold3 for linear peptides and HighFold3 for cyclic peptides, we successfully model the conformation of the linear peptide drug Relamorelin and the cyclic therapeutic peptides LUNA18 and JNJ-77242113 in complex with their target proteins, elucidating structural determinants of their mechanism of action. This work establishes a scalable and accurate framework for structure prediction of diverse nonstandard peptides, highlighting its potential to accelerate rational design of peptide-based therapeutics.

Indexed as

Amino AcidsComputational BiologyModels, MolecularProteinsSoftwareAlgorithmsAmino Acid SequencePrediction AlgorithmsProtein ConformationAmino AcidsProteinsnoncanonical amino acidspeptide drugstructure prediction

Identifiers

PMID42218720
PMCPMC13222519

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.